UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 13-4204626 (State or other jurisdiction of (I.R.S. Employer Form 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2018 or incorporation o ...

| --- | --- | |--------------------------|-------| | | | | | | | | | | 2018 4Q | | | Earnings Call Supplement | | | February 11, 2019 | | | | | | | | Cautionary Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This slide presentation and our accompanying oral remarks contain forward-looking statements regarding, without limitation, our business, operations, turnaround, plans, guidance, projections and longer-term outlook within the meaning of Section 27A of the Sec ...

Molina Healthcare, Inc. (NYSE:MOH) Q4 2018 Earnings Conference Call February 12, 2019 8:30 AM ET Company Participants Ryan Kubota - VP, IR Joseph Zubretsky - CEO Thomas Tran - CFO Conference Call Participants Joshua Raskin - Nephron Research LLC Justin Lake - Wolfe Research LLC Ana Gupte - Leerink Partners LLC David Windley - Jefferies LLC Stephen Tanal - Goldman Sachs & Co. LLC Sarah James - Piper Jaffray & Co. Kevin Fischbeck - Bank of America Merrill Lynch Zachary Sopcak - Morgan Stanley & Co. LLC Gary T ...